Legend Biotech

Identify Access Manager

Franklin Township, New Jersey, United States

$60,000 – $90,000Compensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Information Security, CybersecurityIndustries

Requirements

Candidates should possess a Bachelor’s degree in Computer Science, Information Security, or a related field, and have at least 5 years of experience in Identity and Access Management (IAM) within a complex enterprise environment. Strong knowledge of IAM principles, protocols, and technologies is required, including experience with IGA tools and Directory Services environments such as Azure and AWS. Experience with security frameworks and NIST cybersecurity standards is also beneficial.

Responsibilities

The Identify Access Manager will support enterprise-wide cybersecurity IAM operations using vendor security tools, implement IAM strategy aligned with company objectives, lead the deployment and integration of IGA tool, manage the day-to-day operations of the IAM program, collaborate with cross-functional teams to define IAM policies, coordinate regular audits, provide leadership and guidance to staff, drive adoption of IAM technologies, ensure compliance with regulatory requirements, develop and deliver training programs, design and maintain Directory Services environments, and architect secure IAM designs.

Skills

IAM
IGA Tools
Azure
AWS
Directory Services
Security Frameworks
NIST Cybersecurity Standards
Directory Services
IAM Policies
Compliance
Training
Security Architecture

Legend Biotech

Develops and commercializes cell therapies

About Legend Biotech

Legend Biotech develops and commercializes cell therapies aimed at treating serious diseases, particularly cancers like hematological malignancies and solid tumors. Their approach is technology agnostic, allowing them to explore various methods to find effective treatments. The company operates in the personalized medicine sector, focusing on discovering, developing, and bringing new therapies to market. They generate revenue through licensing and selling their therapies, including CAR-T therapies, which involve modifying a patient's cells to combat cancer. Legend Biotech emphasizes transparency with investors, regularly updating them on financial results and business developments.

Key Metrics

Franklin Township, New JerseyHeadquarters
2014Year Founded
$146.4MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Paid Sick Leave
Paid Holidays
Remote Work Options

Risks

Increased competition from Amgen's Imdelltra may impact CAR-T therapy focus.
Collaboration with Multiply Labs may face technological challenges, delaying production timelines.
Financial strain from new R&D facility could affect operational focus if advancements lag.

Differentiation

Legend Biotech focuses on novel cell therapies for oncology, including CAR-T and NK cells.
The company is technology agnostic, exploring multiple platforms for effective cancer treatments.
Legend Biotech's CARVYKTI® is the first BCMA-targeted CAR-T therapy approved for second-line use.

Upsides

Recent FDA and European approvals for CARVYKTI® expand its market reach in multiple myeloma.
New R&D facility in Philadelphia boosts innovation in next-generation cell therapies.
Alan Bash's appointment could accelerate CARVYKTI®'s growth and market penetration.

Land your dream remote job 3x faster with AI